These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 4195280
1. [In-vivo control of blood coagulation fractions]. Richter K, Rex JO, Stinner G, Fünfhausen G. Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):344-8. PubMed ID: 4195280 [No Abstract] [Full Text] [Related]
2. [Hemophilia as a medical and social problem]. Nosotti NM. Minerva Med; 1972 Dec 01; 63(86):4677-9. PubMed ID: 4642650 [No Abstract] [Full Text] [Related]
3. New alternatives and strategies in the treatment of inhibitors. Hoyer LW. Prog Clin Biol Res; 1984 Dec 01; 150():367-72. PubMed ID: 6431440 [Abstract] [Full Text] [Related]
5. A 1973 look at hemophilia and von Willebrand's disease. Ratnoff OD. Proc Inst Med Chic; 1973 Jul 01; 29(9):296-304. PubMed ID: 4581203 [No Abstract] [Full Text] [Related]
6. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications]. Allain JP. Nouv Rev Fr Hematol; 1972 Jul 01; 12(2):241-9. PubMed ID: 4264617 [No Abstract] [Full Text] [Related]
7. [Substitution therapy of coagulopathies]. Beeser H, Egli H. Infusionstherapie (1973); 1974 Aug 01; 1(6):447-53. PubMed ID: 4466806 [No Abstract] [Full Text] [Related]
8. A comparison between a serum fraction and FEIBA fraction in haemophilia. Hutton RA, Dormandy K, Nour-Eldin F. New Istanbul Contrib Clin Sci; 1980 Aug 01; 13(1):9-22. PubMed ID: 6774316 [No Abstract] [Full Text] [Related]
9. [Inhibitor hemophilia in oral surgery]. Schulz S. Zahn Mund Kieferheilkd Zentralbl; 1984 Aug 01; 72(8):824-8. PubMed ID: 6240865 [No Abstract] [Full Text] [Related]
10. Transfusion support for haemophiliacs. Allain JP. Clin Haematol; 1984 Feb 01; 13(1):99-117. PubMed ID: 6426835 [No Abstract] [Full Text] [Related]
11. Effect of phospholipid on factor VIII inactivation. Barrowcliffe TW, Kemball-Cook G, Gray E. Prog Clin Biol Res; 1984 Feb 01; 150():251-63. PubMed ID: 6431431 [No Abstract] [Full Text] [Related]
12. [Transfusion therapy of hemophilia A and B]. Egli H. Bibl Haematol; 1967 Feb 01; 27():204-10. PubMed ID: 5595089 [No Abstract] [Full Text] [Related]
13. [Substitution therapy with factor 8 and factor IX preparations]. Landbeck G. Hamatol Bluttransfus; 1968 Feb 01; 5():29-42. PubMed ID: 5729465 [No Abstract] [Full Text] [Related]
14. [Long-term treatment of hemophilia A with plasma fractions]. Mey U, Gaerisch F. Folia Haematol Int Mag Klin Morphol Blutforsch; 1970 Feb 01; 93(3):357-62. PubMed ID: 4195282 [No Abstract] [Full Text] [Related]
15. Serum transfusion in hemophiliacs. Kimura A. Tohoku J Exp Med; 1973 Oct 01; 111(2):125-36. PubMed ID: 4784393 [No Abstract] [Full Text] [Related]
16. Orthotopic liver transplantation in a patient with combined hemophilia A and B. Delorme MA, Adams PC, Grant D, Ghent CN, Walker IR, Wall WJ. Am J Hematol; 1990 Feb 01; 33(2):136-8. PubMed ID: 2105634 [Abstract] [Full Text] [Related]
17. Clotting factor concentrates in clinical practice. Standardization and assay. Barrowcliffe TW. Semin Thromb Hemost; 1993 Feb 01; 19(1):73-9. PubMed ID: 8456326 [No Abstract] [Full Text] [Related]
18. [Advances in the field of hemophilia therapy]. Loeliger EA, Veltkamp JJ. Ned Tijdschr Geneeskd; 1968 Sep 07; 112(36):1593-5. PubMed ID: 5680135 [No Abstract] [Full Text] [Related]
19. [Coagulation factors. Indications and applications]. Stampfli K, Hartmann S. Ther Umsch; 1984 Aug 07; 41(8):571-5. PubMed ID: 6437000 [No Abstract] [Full Text] [Related]
20. Physiologic considerations in the management of hemophilia. Briggs DK. Pathobiol Annu; 1971 Aug 07; 1():205-14. PubMed ID: 4950380 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]